Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ
.
Saved in:
| Main Authors: | Sh. Kh. Gantsev, Kazuo Umezawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2019-04-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/368 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INHIBITION OF CANCER CELL INVASION AND METASTASIS BY NF-KAPPA-B INHIBITORS (ИНГИБИРОВАНИЕ ИНВАЗИИ РАКОВЫХ КЛЕТОК И МЕТАСТАЗОВ ПРИ ПОМОЩИ ИНГИБИТОРОВ NF-КАППА-B)
by: T. Ukaji, et al.
Published: (2017-02-01) -
Antitumour Activity of Dehydroxymethylepoxyquinomycin (DHMEQ): a Literature Review
by: K. Umezawa, et al.
Published: (2021-04-01) -
Isoliquiritigenin Alleviates Periodontitis by Suppressing Inflammation via NF-κB Signaling Pathway of Immune Cell
by: Wang X, et al.
Published: (2025-05-01) -
YTHDF1 Regulates RELA m6A Modification and Activates the NF‐Kappa B Signaling Pathway to Promote the Mechanism of Gastric Cancer
by: Yangyuan Huang, et al.
Published: (2025-01-01) -
Defining critical roles for NF‐κB p65 and type I interferon in innate immunity to rhinovirus
by: Nathan W. Bartlett, et al.
Published: (2012-11-01)